LOX-elicited TAMs infiltrate the tumor microenvironment and support glioma growth via SPP1 (osteopontin), which inhibits glioma cell apoptosis, promotes angiogenesis and sustains the TAM tolerogenic phenotype by signaling through the Integrin αvβ5 (49, 50). Here, LOX is linked to central nervous system cancer.